Skip to content

Webinar: Cytokine adsorption in severely ill COVID-19 patients

The Webinar: Cytokine adsorption in severely ill COVID-19 patients – rationale and clinical experience
Chairs: Prof. John Kellum, Pittsburgh, USA and Prof. Luciano Gattinoni; Göttingen, Germany

  • Introduction - Why hemoadsorption seems to be a useful treatment option
    John Kellum
  • Safety and feasibility of CytoSorb therapy in COVID-19 patients – the Wuhan experience
    Zhiyong Peng
  • It is more than just Cytokine removal - the Bergamo and Triest experience
    Ivano Riva and Giorgio Berlot
  • Combination of ECMO and CytoSorb in COVID-19 patients – when and how should we do it
    Alexander Supady
  • We have to collect data to create evidence! CYTOAID - an international multicenter observational trial
    Peter Hegyi
  • Summary
    Luciano Gattinoni
Play Video

Share

|

Webinar: Cytokine adsorption in severely ill COVID-19 patients

Play Video

Share

|

The Webinar: Cytokine adsorption in severely ill COVID-19 patients – rationale and clinical experience
Chairs: Prof. John Kellum, Pittsburgh, USA and Prof. Luciano Gattinoni; Göttingen, Germany

  • Introduction - Why hemoadsorption seems to be a useful treatment option
    John Kellum
  • Safety and feasibility of CytoSorb therapy in COVID-19 patients – the Wuhan experience
    Zhiyong Peng
  • It is more than just Cytokine removal - the Bergamo and Triest experience
    Ivano Riva and Giorgio Berlot
  • Combination of ECMO and CytoSorb in COVID-19 patients – when and how should we do it
    Alexander Supady
  • We have to collect data to create evidence! CYTOAID - an international multicenter observational trial
    Peter Hegyi
  • Summary
    Luciano Gattinoni